RecallDepth
Class II Terminated

Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 mg per 30 mL (5 mg per mL), 30 mL Single Dose Vial (NDC 63323-462-01), packaged as 25 Single Dose Vials per tray (NDC 63323-462-37), Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

This recall has been terminated (originally issued December 30, 2020).

Company
Fresenius Kabi Usa, Llc
Recall Initiated
December 10, 2020
Posted
December 30, 2020
Recall Number
D-0172-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4411 trays
Firm Location
Lake Zurich, IL, United States
Official Source
View on FDA website ↗

Reason for Recall

Subpotent Drug: Low out-of-specification assay results for the epinephrine component.

Distribution

Nationwide in the USA

Lot / Code Info

Batch # 6123760, Exp 02/2022

More recalls by Fresenius Kabi Usa, Llc

View all recalls by this company →

Other recent Class II Drug recalls